Director Sanchez Juan bought Nuvectis Pharma ($NVCT) shares once on the open market in the past year, totaling about $75,000, with the latest purchase on November 5, 2025. This ranks 2,631st among nearly 5,000 insiders by purchase value, below the average of $1.5 million across about 3.3 transactions per insider. Juan reported no open market sales in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 5, 2025 | Nuvectis Pharma, Inc. | $NVCT | Sanchez Juan | Director | P | Common Stock | 13000 | $5.79 | 78,565.0000 | 22,719,057 | 19.83% | 0.06% |
| Sept. 22, 2025 | Nuvectis Pharma, Inc. | $NVCT | Sanchez Juan | Director | A | Common Stock | 30000 | $0.00 | 65,565.0000 | 21,366,268 | 84.35% | 0.14% |